| Name | 1-(4-chloro-3-methylsulfonylphenyl)propan-2-one |
|---|---|
| Synonyms |
1-(4-Chloro-3-(methylsulfonyl)phenyl)propan-2-one
1-(4-chloro-3-methanesulfonylphenyl)propan-2-one |
| Molecular Formula | C10H11ClO3S |
|---|---|
| Molecular Weight | 246.71100 |
| Exact Mass | 246.01200 |
| PSA | 59.59000 |
| LogP | 2.95580 |
| HS Code | 2914700090 |
|---|
|
~67%
593960-75-9 |
| Literature: CHROMA THERAPEUTICS LTD Patent: WO2006/117567 A2, 2006 ; Location in patent: Page/Page column 83 ; |
|
~%
593960-75-9 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/78754 A1, 2004 ; Location in patent: Page 37-38 ; WO 2004/078754 A1 |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2914700090 |
|---|---|
| Summary | HS: 2914700090 halogenated, sulphonated, nitrated or nitrosated derivatives of ketones and quinones, whether or not with other oxygen function Tax rebate rate:9.0% Supervision conditions:none VAT:17.0% MFN tariff:5.5% General tariff:30.0% |